This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Assistance Publique-Hopitaux De Paris, National Institute of Health and Medical Research, Université Paris-Saclay. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:





Years Active: 2025-2026
Title: Ali Turhan: Innovator in Cancer Treatment
Introduction
Ali Turhan is a notable inventor based in Villejuif, France. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on developing new therapeutic strategies that target cancers expressing embryonic antigens.
Latest Patents
Ali Turhan holds a patent for "Methods and compositions for treating cancers." This invention provides a novel approach to treating subjects suffering from cancer. The method involves administering a population of derived engineered fetal stem cells carrying cancer-associated fetal neo-antigens, along with a compound that activates the immune response. This combined preparation aims to enhance the therapeutic efficacy against cancer.
Career Highlights
Throughout his career, Ali Turhan has worked with prestigious institutions, including the Institut National de la Santé et de la Recherche Médicale (INSERM) and Assistance Publique-Hôpitaux de Paris. His experience in these organizations has allowed him to collaborate with leading experts in the field of medical research.
Collaborations
Ali Turhan has collaborated with notable colleagues, including Frank Griscelli and Annelise Bennaceur Griscelli. These partnerships have contributed to the advancement of his research and the development of innovative cancer treatment methods.
Conclusion
Ali Turhan's work in cancer treatment exemplifies the impact of innovative research on medical science. His patented methods offer promising avenues for improving therapeutic strategies against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile